Related Experiment Videos
Do thiazide diuretics confer specific protection against strokes?
Franz H Messerli1, Ehud Grossman, Anthony F Lever
1Department of Internal Medicine, Section on Hypertensive Diseases, Ochsner Clinic Foundation, 1514 Jefferson Highway, New Orleans, LA 70121, USA. fmesserli@aol.com
Insights
Thiazide diuretics offer stroke risk reduction beyond blood pressure control. These benefits extend to combination therapies, suggesting a unique cerebroprotective effect for hypertensive patients.
Area of Science:
- Cardiology
- Neurology
- Pharmacology
Background:
- High blood pressure is a major risk factor for stroke.
- Existing antihypertensive therapies may not fully address cerebrovascular risk.
- The specific mechanisms of stroke prevention by different drug classes require clarification.
Purpose of the Study:
- To evaluate the cerebroprotective effects of thiazide diuretics.
- To determine if this effect is independent of blood pressure reduction.
- To compare the cerebroprotective potential of thiazide diuretics with other drug classes.
Main Methods:
- Analysis of large-scale studies on antihypertensive therapies.
- Comparison of stroke risk reduction across different drug classes (thiazide diuretics, beta-blockers, ACE inhibitors).
- Assessment of effects in patients with and without manifest cardiovascular disease.
Main Results:
- Thiazide diuretics demonstrated a significant reduction in stroke risk.
- This benefit appeared independent of their blood pressure-lowering effects.
- Other drug classes, like beta-blockers and ACE inhibitors, did not show a similar cerebroprotective effect in patients without manifest cardiovascular disease.
Conclusions:
- Thiazide diuretics possess a unique cerebroprotective property.
- Low-dose thiazide diuretics are recommended for hypertensive patients at risk of stroke, either as initial therapy or in combination.
- This highlights the importance of thiazide diuretics in comprehensive stroke prevention strategies.
Abstract:
Several large studies have suggested that therapy with thiazide diuretics confers a particular benefit in reducing the risk of strokes that seem to be, at least to some extent, independent of the blood pressure-lowering effect. Such a cerebroprotective effect was documented not only with monotherapy but also when diuretics were used in combination with other drugs. The cerebroprotective effect does not seem to be shared by other drug classes, such as the beta-blockers or the angiotensin-converting enzyme inhibitors, in patients without manifest cardiovascular disease. Since stroke is one of the most devastating sequelae of high blood pressure, our data strongly favor the use of low-dose diuretics either as initial therapy or in combination in all hypertensive patients at risk for cerebrovascular disease.
Related Concept Videos
Antihypertensive Drugs: Thiazide-Class Diuretics
Antihypertensive Drugs: Potassium-Sparing Diuretics
Heart Failure Drugs: Diuretics
Antihypertensive Drugs: Action of Diuretics
Hypertension IV: Drug Therapy and Lifestyle Modifications
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...